公司历程_Avatarget-Lingking Organchip, Lingking Health

中文 ENGLISH

Corporate Briefs

Industry Insights

Media promotion

The project of human organ-on-chip and multimodal precision measurement method construction selected as one of China’s Top 10 Science Advances in 2023

2024-03-01

The project of human organ-on-chip and multimodal precision measurement method construction selected as one of China’s Top 10 Science Advances in 2023

The project of human organ-on-chip and multimodal precision measurement method construction selected as one of China’s Top 10 Science Advances in 2023

2024-03-01

The project of human organ-on-chip and multimodal precision measurement method construction selected as one of China’s Top 10 Science Advances in 2023

The Center of NMPA issued the Technical Guidelines on Non-clinical Studies of Human Stem Cell-based Products, which explicitly includes new technologies such as organoid into the evaluation models for non-clinical studies of human stem cell-based

2024-01-01

The Center of NMPA issued the Technical Guidelines on Non-clinical Studies of Human Stem Cell-based Products, which explicitly includes new technologies such as organoid into the evaluation models for non-clinical studies of human stem cell-based

The first space OoC culture experiment in Chinese’s space station, also the first international Taikonaut-Blood-Vessels-on-a-Chip study

2023-08-01

The first space OoC culture experiment in Chinese’s space station, also the first international Taikonaut-Blood-Vessels-on-a-Chip study

HRS-1893 tablets were approved for clinical trials, which is the first breakthrough of organoid data outside the realm of CGT drugs

2023-05-01

HRS-1893 tablets were approved for clinical trials, which is the first breakthrough of organoid data outside the realm of CGT drugs

U.S. President Biden signed into law the FDA Modernization Act 2.0, eliminating federal mandatory requirement for animal testing for new and generic drugs

2022-12-01

U.S. President Biden signed into law the FDA Modernization Act 2.0, eliminating federal mandatory requirement for animal testing for new and generic drugs

General Technical Requirement of Skin-on-a-chip, China’s first draft technical standard for OoCs, was published

2022-08-01

General Technical Requirement of Skin-on-a-chip, China’s first draft technical standard for OoCs, was published

For the first time, the FDA had approved the clinical trial of an investigational therapy based solely on preclinical efficacy data obtained in human OoC studies

2022-08-01

For the first time, the FDA had approved the clinical trial of an investigational therapy based solely on preclinical efficacy data obtained in human OoC studies

The U.S. House of Representatives passed the Food and Drug Amendments of 2022, which includes OoCs and Microphysiological Systems (MPSs) as independent systems for evaluating drugs in non-clinical trials

2022-06-01

The U.S. House of Representatives passed the Food and Drug Amendments of 2022, which includes OoCs and Microphysiological Systems (MPSs) as independent systems for evaluating drugs in non-clinical trials

Organoid research has been approved as a key special project of the National Key R&D Program in China’s 14th Five-Year Plan

2021-01-01

Organoid research has been approved as a key special project of the National Key R&D Program in China’s 14th Five-Year Plan

The Center of NMPA published the Technical Guidelines on Nonclinical Studies of Genetically Modified Cell Therapy Products, allowing for the use of cell- and tissue-based models to provide useful supplemental information for efficacy and safety evaluation

2021-01-01

The Center of NMPA published the Technical Guidelines on Nonclinical Studies of Genetically Modified Cell Therapy Products, allowing for the use of cell- and tissue-based models to provide useful supplemental information for efficacy and safety evaluation

Southeast University in China developed a bronchial-lung-on-chip that could be used for the evaluation of COVID-19 infections and treatments, and applied it at the Jiangsu Provincial Center for Disease Control and Prevention

2020-02-01

Southeast University in China developed a bronchial-lung-on-chip that could be used for the evaluation of COVID-19 infections and treatments, and applied it at the Jiangsu Provincial Center for Disease Control and Prevention

< 1 2 >

Service Hotline(front desk)

+86 025-58858435

Picture Name

WeChat

Picture Name

Zhihu

Picture Name

Bilibili

©2023 Jiangsu Avatarget Biotechnology Co., Ltd. All rights reserved Website Construction:China Enterprise Power Kunshan SEO

Business License

We use optional cookies to improve your experience on our website, including through social media connections, and to personalize ads based on your online activity. If you refuse optional cookies, we will only use cookies that are necessary to provide you with the services.Privacy Statement